Centre Hospitalier Regional Et Universitaire De Brest

At Centre Hospitalier Regional Et Universitaire De Brest, clinical research in oncology is focused on improving care for people with Triple Negative Breast Cancer, especially those with residual disease after initial treatment. The studies are designed to better understand whether adding or adjusting treatment after surgery can improve outcomes for patients with this aggressive cancer type.

• Evaluating new treatment strategies for Triple Negative Breast Cancer
• Assessing the benefit of additional therapy after surgery in patients with residual disease
• Studying ways to improve invasive disease-free survival and long-term cancer control

This work reflects a strong focus on cancer treatment effectiveness and post-operative care within the hospital’s Institut de cancérologie et d'hématologie.